Bayes-Corrected Scoring Matrix for T-Cell Epitope Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying and optimizing T-cell epitopes are resource-intensive and lack efficient computational tools for predicting binding affinities to MHC molecules, hindering the development of effective epitope-based vaccines and immunotherapeutics.

Innovation Solution

A computational tool using a Bayes-corrected scoring matrix to predict and optimize T-cell epitopes by analyzing amino acid sequences for binding preferences to MHC class I alleles, incorporating filters for natural processing, self-similarity, and immunogenic enhancement to identify peptides that can elicit stronger immune responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If computational tools are used to predict T-cell epitopes, then productivity is improved, but measurement precision deteriorates

Engineering Contradiction:
Improveepitope identification efficiencyVSAvoidbinding affinity prediction accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The method segments the epitope prediction process into multiple filtering stages: initial binding affinity screening using computational tools, followed by sequential application of natural processing filters, self-similarity filters, and immunogenicity enhancement filters. This segmentation allows high-throughput computational screening while progressively refining results to improve prediction accuracy at each stage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces multiple intermediary filtering mechanisms between the initial computational prediction and final epitope selection. These intermediaries (natural processing filters, self-similarity filters, immunogenicity filters) act as mediators that refine computational predictions by applying additional biological and immunological criteria, thereby improving overall measurement precision while maintaining productivity benefits.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If multiple filtering criteria are applied to optimize epitopes, then manufacturing precision is improved, but device complexity increases

Engineering Contradiction:
Improveepitope optimization accuracyVSAvoidcomputational system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The computational system is segmented into distinct, modular filtering components: binding affinity prediction module, natural processing filter, self-similarity filter, and immunogenicity enhancement filter. Each module performs a specific function with well-defined inputs and outputs, making the overall complex system manageable through functional segmentation and enabling independent optimization of each component.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system optimizes epitopes by systematically changing multiple parameters including amino acid sequence composition, MHC binding affinity values, processing likelihood scores, self-similarity metrics, and immunogenicity indices. Each filter adjusts specific parameters independently, allowing precise control over epitope optimization while organizing complexity through parameter-specific processing.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS7756644B2System and method for automated selection of T-cell epitopes
Publication Date: 2010.07.13 MERCK SHARP & DOHME LLC
  • US7756644B2 patent drawing
  • US7756644B2 patent drawing
  • US7756644B2 patent drawing

AI summary

Methodology for the automated selection and/or optimization of T-cell epitopes is disclosed. The invention provides a data processing system which utilizes sequence-based statistical pattern recognition to compute an epitope selection matrix based on the informational content of epitopes known to bind to a particular major histocompatibility class I allele. The resulting Bayes-corrected scoring matrix is used to predict the relative binding affinities of candidate T-cell epitopes derived from immunologically relevant antigens of self or foreign origin. One aspect of the invention describes an analytical method for identification of modifications in known or predicted T-cell epitopes that confer upon the epitopes the ability to elicit stronger cellular immune response due to more efficient processing and/or presentation to T-cells. The disclosed epitope identification algorithm is applicable to the design of vaccines for infectious diseases, cancer and autoimmune diseases as well as for developing methods for the in vitro evaluation of cellular immunity.